{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:26:45Z","timestamp":1793982405563,"version":"4.8.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpainsymman.2026.07.030","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:20:59Z","timestamp":1785738059000},"page":"603-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1959-5614","authenticated-orcid":false,"given":"Daniel A.","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle K.","family":"Leff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Leeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-6272","authenticated-orcid":false,"given":"Benjamin S.","family":"Kematick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Beaussant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpainsymman.2026.07.030_bib0001","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12888-025-06599-5","article-title":"Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses","volume":"25","author":"Getie","year":"2025","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.jpainsymman.2026.07.030_bib0002","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3390\/jcm12062196","article-title":"The impact of depression and anxiety on adult cancer patients\u2019 health-related quality of life","volume":"12","author":"Alwhaibi","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jpainsymman.2026.07.030_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/02841860701460541","article-title":"Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy","volume":"47","author":"Wedding","year":"2008","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.jpainsymman.2026.07.030_bib0004","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1200\/JCO.2011.40.8922","article-title":"Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis","volume":"31","author":"Faller","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.jpainsymman.2026.07.030_bib0005","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"12","key":"10.1016\/j.jpainsymman.2026.07.030_bib0006","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"issue":"7","key":"10.1016\/j.jpainsymman.2026.07.030_bib0007","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cncr.35010","article-title":"Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder","volume":"130","author":"Agrawal","year":"2024","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jpainsymman.2026.07.030_bib0008","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35889","article-title":"Long-term benefits of single-dose psilocybin in depressed patients with cancer","volume":"131","author":"Agrawal","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jpainsymman.2026.07.030_bib0009","first-page":"53","article-title":"Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC\/ESMO consensus recommendation","volume":"32","author":"Jordan","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2026.07.030_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1391689","article-title":"In vitro and in vivo metabolism of psilocybin's active metabolite psilocin","volume":"15","author":"Thomann","year":"2024","journal-title":"Front Pharmacol"},{"issue":"24","key":"10.1016\/j.jpainsymman.2026.07.030_bib0011","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa011871","article-title":"The effect of group psychosocial support on survival in metastatic breast cancer","volume":"345","author":"Goodwin","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426009164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426009164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:03:54Z","timestamp":1793981034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392426009164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0885392426009164"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.07.030","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}